MedTrace Logo

Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays

NCT01702103 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2012-10-05

No results posted yet for this study

Summary

Demonstrate the therapeutic clinical equivalence of two mometasone nasal sprays in the relief of the signs and symptoms of perennial allergic rhinitis, in term of changes at week 8 from baseline of Total Nasal Symptom Scores (TNSS).

Conditions

  • Nasal Obstruction
  • Sneezing
  • Itching

Interventions

DRUG

Mometasone furoate

Sponsors & Collaborators

  • PH&T S.p.A.

    lead INDUSTRY

Principal Investigators

  • Alessandro Mazzetti, MD · Sintesi Research Srl

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-01-31
Completion
2013-03-31

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01702103 on ClinicalTrials.gov